Skin cancer risk discussions in melanoma-affected families

Journal of Cancer Education

Volumn 20, Issue 4, 2005, Pages 240-246

  Hay, Jennifer ^a   Ostroff, Jamie ^a   Martin, Alisa ^b   Serle, Nicole ^c   Soma, Sireesha ^d   Mujumdar, Urvi ^a   Berwick, Marianne ^e  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Long Island Jewish Hospital   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER RISK; FAMILIAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATIENT EDUCATION; PRIORITY JOURNAL; RELATIVE; SELF REPORT; SKIN CANCER;

ADULT; AGED; AGED, 80 AND OVER; COMMUNICATION; CROSS-SECTIONAL STUDIES; FAMILY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MELANOMA; MIDDLE AGED; RISK FACTORS; SKIN NEOPLASMS;

EID: 33344455452     PISSN: 08858195     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15430154jce2004_13     Document Type: Article

References (52)

1. Jemal A, Devesa SS, Hartge P, et al. Recent trends in cutaneous melanoma incidence among Whites in the United States. J Natl Cancer Inst. 2001;93:678-683.
2. Geller AC, Miller DR, Annas GD, et al. Melanoma incidence and mortality among US Whites, 1969-1999. JAMA. 2002;288:1719-1720.
3. Clegg LX, Feuer EJ, Midthune DN, et al. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002;94:1537-1545.
4. Howe HL, Wingo PA, Thun MJ, et al. The annual report to the nation on the status of cancer (1973-1998), featuring cancers with recent increasing trends. J Natl Cancer Inst. 2001;93:824-842.
5. Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res. 1993;3:395-401.
6. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA. 1997;277:1439-1444.
7. Armstrong BK, English DR. Cutaneous malignant melanoma. In: Schottenfeld DR, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 2nd ed. New York, NY: Oxford University Press; 1996:1282-1312.
8. Gilchrest BA, Eller MS, Geller AC, et al. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340:1341-1348.
9. Berwick M. Epidemiology: Current trends, risk factors, and environmental concerns. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, eds. Cutaneous Melanoma. 3rd ed. St. Louis, MO: Quality Medical Publishing; 1998:551-572.
10. Ford D, Bliss JM, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer. 1995;62:377-381.
11. Rogers RS. Malignant melanoma in the 21st century. Int J Dermatol. 2000;39:178-179.
12. Autier P, Dore JF. Influence of sun exposures during childhood and during adulthood on melanoma risk. Int J Cancer. 1998;77:533-537.
13. Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol. 2001;117:294-300.
14. Schaffer JV, Bolgnia JL. The melanocortin-1 receptor, red hair and beyond. Arch Dermatol. 2001;137:1477-1485.
15. van der Velden PA, Sandkuijl LA, Bergman W, et al. Melonocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet. 2001;69:774-779.
16. Goldstein AM, Falk RT, Fraser MC, et al. Sun-related risk factors in melanoma-prone families with CDKN2A mutations. J Natl Cancer Inst. 1998;90:709-711.
17. Goldstein AM, Tucker MS. Screening for CDKN2A mutations in hereditary melanoma. J Natl Cancer Inst. 1997;89:676-678.
18. Monzon J, Liu L, Brill H, et al. CDKN2A mutations in multiple primary melanomas. N Engl J Med. 1998;26:879-887.
19. Brandberg Y, Bolund C, Michelson H, et al. Perceived susceptibility to and knowledge of malignant melanoma: screening participants vs the general population. Prev Med. 1996;25:170-177.
20. Friedman LC, Bruce S, Webb JA, et al. Skin self-examination in a population at increased risk for skin cancer. Am J Prev Med. 1993;9:359-364.
21. Geller AC, Emmons K, Brooks DR, et al. Skin cancer prevention and detection practices among siblings of patients with melanoma. J Am Acad Dermatol. 2003;49:631-638.
22. Geller AC, Koh HK, Miller DR, et al. Practices and beliefs concerning screening family members of patients with melanoma. J Am Acad Dermatol. 1992;26(pt 2):419-422.
23. Jackson A, Wilkinson C, Hood K, et al. Does experience predict knowledge and behavior with respect to cutaneous melanoma, moles, and sun exposure? Possible outcome measures. Behav Med. 2000;26:74-79.
24. McGuire DB. Preventive health practices and educational needs in families with hereditary melanoma. Cancer Nurs. 1985;8:29-36.
25. Manne S, Fasanella N, Connors J, et al. Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: Prevalence and predictors. Prev Med. 2004;36-47
26. Bergenmar M, Brandberg Y. Sunbathing and sun-protection behaviors and attitudes of young Swedish adults with hereditary risk for malignant melanoma. Cancer Nurs. 2001;24:341-350.
27. Maser E, Berg D. Changes in patient perception and behavior following Mohs micrographic surgery. J Cutan Med Surg. 2001;5:14-17.
28. de Rooij MJ, Rampen FH, Schouten LJ, et al. Factors influencing participation among melanoma screening attenders. Acta Derm Venereol. 1997;77:467-470.
29. Koh HK, Miller DR, Geller AC, et al. Who discovers melanoma? Patterns from a population-based survey. J Am Acad Dermatol. 1992;26:914-919.
30. Polednak AP. Malignant melanoma of the skin in Upstate New York: recent trends and characteristics. Cancer Detect Prev. 1985;8:485-495.
31. Robinson JK, Rademaker AW. Skin cancer risk and sun protection learning by helpers of patients with nonmelanoma skin cancer. Prev Med. 1995;24:333-341.
32. Bandura, A. Social foundations of thought and action: A social cognitive theory. Upper Saddle River, NJ: Prentice-Hall; 1986.
33. Glanz K, Lew RA, Song V, et al. Factors associated with skin cancer prevention practices in a multiethnic population. Health Educ Behav. 1999;26:344-359.
34. Halverson PK, Mays GP, Rimer BK, et al. Adoption of a health education intervention for family members of breast cancer patients. Am J Prev Med. 2000;18:189-198.
35. Kristeller JL, Herbert J, Edmiston K, et al. Attitudes toward risk factor behavior of relatives of cancer patients. Prev Med. 1996;25:162-169.
36. Schilling A, Conaway MR, Wingate PJ, et al. Recruiting cancer patients to participate in motivating their relatives to quit smoking. Cancer. 1997;79:152-160.
37. Audrain-McGovern J, Hughes C, Patterson F. Effecting behavior change: awareness of family history. Am J Prev Med. 2003;24:183-189.
38. Begg C, Hummer A, Mujumdar U, et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004;15(9):957-965.
39. Hughes C, Lerman C, Schwartz M, et al. All in the family, evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet. 2002;107:143-150.
40. Lerman C, Trock B, Rimer BK, et al. Psychological side effects of breast cancer screening. Health Psychol. 1991;10:259-267.
41. Weinstein ND. Unrealistic optimism about future life events. J Pers Soc Psychol. 1980;39:806-820.
42. Weinstein ND. Unrealistic optimism about susceptibility to health problems. J Behav Med. 1982;5:441-460.
43. McLaughlin JK, Dietz MS, Mehl ES, et al. Reliability of surrogate information on cigarette smoking by type of informant. Am J Epidemiol. 1987;126:144-146.
44. Claes E, Evers-Kiebooms G, Boogaerts A, et al. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet. 2003;116A:11-19.
45. Liede A, Metcalfe K, Hanna D, et al. Evaluation of the needs of male carriers in BRCA1 or BRCA2 who have undergone genetic counseling. Am J Hum Genet. 2000;67:1494-1504.
46. Weinstock MA. Do sunscreens increase or decrease melanoma risk: an epidemiologic evaluation. J Investig Dermatol Symp Proc. 1999;4:97-100.
47. Benedict S, Coon G, Hoomani J, et al. Breast cancer detection by daughters of women with breast cancer. Cancer Pract. 1997;5:213-219.
48. Daly M, Farmer J, Harrop-Stein C, et al. Exploring family relationships in cancer risk counseling using the genogram. Cancer Epidemiol Biomarkers Prev. 1999;8(pt 2):393-398.
49. Daly MB, Barsevick M, Miller SM, et al. Communicating genetic test results to the family: a six-step, skills-building strategy. Fam Community Health. 2001;24:13-26.
50. Hughes C, Lynch H, Durham C, et al. Communication of BRCA1/2 test results in hereditary breast cancer families. Cancer Res Ther Control. 1999;8:51-59.
51. Julian-Reynier C, Eisinger F, Chabal F, et al. Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors. Am J Med Genet. 2000;94:13-18.
52. Lerman C, Peshkin BN, Hughes C, et al. Family disclosure in genetic testing for cancer susceptibility: determinants and consequences. J Health Care Law Policy. 1998;1:353-372.